MDG1:FRA
MediGene AG
0,017 €
arrow_upward
+3,61%(+0,00060) 1 d.
30. 6., 22:00:00 GMT+2 · EUR
search
Všetky symboly
| Symbol | Cena | Zmena | % zmeny |
|---|
Spravodajstvo
Z internetových zdrojov a od spravodajských partnerov
GlobeNewswire
·
pred 39 minútami
Compass Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Quiver Quantitative
·
pred 39 minútami
RedCloud Holdings plc Receives Nasdaq Delisting Determination, Appeals Decision and Plans Share Consolidation
Simply Wall Street
·
pred 12 minútami
Raised Outlook Could Change The Case For NetApp Stock
Seeking Alpha
·
pred 2 hodinami
Nasdaq tumbles 2%, and these 10 stocks have fueled the selloff
Profil
Medigene AG is a publicly listed biotechnology company headquartered in Martinsried near Munich, Germany. Medigene is working on the development of immunotherapies to enhance T cell activity against solid cancers. The first product candidates are in clinical development. Wikipedia